Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Viola

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Children (Basel, Switzerland)|June 28, 2023
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory SyndromeLaura Dotta, Daniele Moratto, Marco Cattalini, et al.
Journal of Gastroenterology and Hepatology|May 20, 2020
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's diseaseFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Journal of Crohn'S & Colitis|October 13, 2025
Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Cancers|November 11, 2022
Intraoperative Evaluation of Brain-Tumor Microvascularization through MicroV IOUS: A Protocol for Image Acquisition and Analysis of Radiomic FeaturesGiuseppe Roberto Giammalva, Anna Viola, Rosario Maugeri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2025
Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Expert Opinion on Biological Therapy|September 28, 2020
Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)Fabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
The British Journal of Radiology|December 17, 2021
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electronsMaria Cristina Leonardi, Andriana Kouloura, Damaris Patricia Rojas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitisFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Inflammatory Bowel Diseases|February 22, 2020
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple SwitchesFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Children (Basel, Switzerland)|June 28, 2023
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory SyndromeLaura Dotta, Daniele Moratto, Marco Cattalini, et al.
Journal of Gastroenterology and Hepatology|May 20, 2020
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's diseaseFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Journal of Crohn'S & Colitis|October 13, 2025
Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Cancers|November 11, 2022
Intraoperative Evaluation of Brain-Tumor Microvascularization through MicroV IOUS: A Protocol for Image Acquisition and Analysis of Radiomic FeaturesGiuseppe Roberto Giammalva, Anna Viola, Rosario Maugeri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2025
Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Expert Opinion on Biological Therapy|September 28, 2020
Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)Fabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
The British Journal of Radiology|December 17, 2021
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electronsMaria Cristina Leonardi, Andriana Kouloura, Damaris Patricia Rojas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitisFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Inflammatory Bowel Diseases|February 22, 2020
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple SwitchesFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Pageof 10